AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75A50123C00012RIGEL PHARMACEUTICALS INC
Overview
Award facts
- Net obligations
- $750K
- $749,999of $750K potential value
- Outlays (paid to date)
- $365K
- $365K paid of $750K obligated$365,000
- Period of performance
- May 1, 2023 to Oct 31, 2025
- Ended
- Modifications
- 6
- Latest action May 21, 2025
- Contract type
- Definitive contract
- PIID 75A50123C00012
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
RIGEL PHARMACEUTICALS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF FOSTAMATINIB TREATMENT DURING HOSPITALIZATION RESULTING FROM ARDS ON LONG-TERM OUTCOMES INCLUDING CLINICAL, BIOMARKER, IMAGING, QOL, FUNCTIONAL AND LUNG FUNCTI
Dates and value
- Award date
- Signed on Apr 20, 2023
- Potential end of performance
- Oct 30, 2025
- Current value
- $749,999Base and exercised options
- Potential value (if all options are exercised)
- $749,999
Obligations by fiscal year of action
- FY2023: $749,999
Total across 1 fiscal year: $749,999
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 21, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationSOUTH SAN FRANCISCO, CA
UEIX7MHPBCMHFM3
CAGE code60TS7
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyRIGEL PHARMACEUTICALS INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- South San Francisco, San Mateo County, California 94080-7552
- Congressional district (place of performance)
- CA-15As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 100
Solicitation and notices
- Solicitation ID
- BAA-20-100-SOL-0002
- Solicitation date
- Feb 3, 2020
- Notices
- Solicitation posted Oct 18, 2022
- Solicitation posted Jun 24, 2022
- Solicitation posted Mar 31, 2022
- Solicitation posted Jan 7, 2022
- Solicitation posted Nov 24, 2021
- Solicitation posted Nov 10, 2021
- Solicitation posted Aug 23, 2021
- Solicitation posted Aug 23, 2021
- Solicitation posted Mar 4, 2021
- Solicitation posted Mar 4, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Rigel pharmaceuticals: evaluation of fostamatinib in mitigating the impact of long-term respiratory
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Apr 20, 2023Base obligation at award: $749,999
- Latest action
- May 21, 2025 — Supplemental agreement (within scope)Modification P00006
- Latest substantive action
- May 21, 2025 — Supplemental agreement (within scope)Modification P00006
- Actions by type
- Base award1
- Other administrative action5
- Supplemental agreement (within scope)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Environmentally preferableF
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 7
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2023/2024-0140-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression